ELLEX Conditions
Ellex ophthalmic lasers and ultrasound systems for treatment of eye conditions including Glaucoma & Diabetic Retinopathy, Cataract and Floaters achieve the highest standard of ophthalmic treatment outcomes.
Laser treatment for Glaucoma & Diabetic Retinopathy
The Ellex ongoing vision is to transform outcomes and quality of life for patients — safely, accurately, effectively and consistently. Ellex is also committed to develop solutions that enable ophthalmologists to focus on proactive patient care through earlier intervention to achieve better results — sustainably and naturally.
Glaucoma
Glaucoma Pro-active care.
The leading cause of blindness in the developed world, glaucoma is a progressive, irreversible eye disease that causes vision loss due to optic nerve damage.
The leading edge ELLEX products give ophthalmologists the ability to treat glaucoma across the full spectrum of the disease and enable significant numbers of patients to minimize or obviate the need for medications to control their glaucoma.
Related products: Tango ReflexTM, TangoTM
Related treatments: Selective Laser Trabeculoplasty
Read more ...
The leading cause of blindness in the developed world, glaucoma is a progressive, irreversible eye disease that causes vision loss due to optic nerve damage.
The leading edge ELLEX products give ophthalmologists the ability to treat glaucoma across the full spectrum of the disease and enable significant numbers of patients to minimize or obviate the need for medications to control their glaucoma.
Related products: Tango ReflexTM, TangoTM
Related treatments: Selective Laser Trabeculoplasty
Diabetic Retinopathy
Combatting, Restoring Naturally.
Alongside Age-Related Macular Degeneration, Diabetic Retinopathy is one of the most common causes of vision loss and blindness in the developed world. It’s estimated that around 366 million people will have diabetes by 2030, and up to 44% of sufferers will develop some form of the disease.
Laser photocoagulation delivered by Ellex's Integre ProTM continues to be a mainstream treatment pathway, and the importance of the approach has grown with the introduction of pattern scanning photocoagulation — exemplified within our Integre Pro ScanTM model — which transforms the efficacy and efficiency of treatment.
Related products: Integre Pro ScanTM, Integre Pro™
Systems: Intergre ProTM Integro Pro ScanTM
Read more ...
Alongside Age-Related Macular Degeneration, Diabetic Retinopathy is one of the most common causes of vision loss and blindness in the developed world. It’s estimated that around 366 million people will have diabetes by 2030, and up to 44% of sufferers will develop some form of the disease.
Laser photocoagulation delivered by Ellex's Integre ProTM continues to be a mainstream treatment pathway, and the importance of the approach has grown with the introduction of pattern scanning photocoagulation — exemplified within our Integre Pro ScanTM model — which transforms the efficacy and efficiency of treatment.
Related products: Integre Pro ScanTM, Integre Pro™
Systems: Intergre ProTM Integro Pro ScanTM
